Leadership transition brings expanded expertise and global vision to the only peer-reviewed journal focused exclusively on CLTI and severe PAD.

MALVERN, Pa. — July 21, 2025 — Dr. Jos C. van den Berg has been named Editor-in-Chief of the Journal of Critical Limb Ischemia, the only peer-reviewed publication dedicated to chronic limb-threatening ischemia (CLTI) and peripheral artery disease (PAD). Published by the Critical Limb Ischemia Global Society and HMP Global, the journal supports global multidisciplinary efforts to prevent amputations and improve vascular outcomes.
 

What is the Journal of Critical Limb Ischemia?

The Journal of Critical Limb Ischemia (JCLI) is a quarterly, peer-reviewed academic journal and the official publication of the Critical Limb Ischemia Global Society (CLIGS). It is the only journal focused entirely on chronic limb-threatening ischemia (CLTI) and severe peripheral artery disease (PAD).

JCLI provides a global platform for multidisciplinary research, clinical trials, registry data, and expert commentary related to the diagnosis, treatment, and management of limb-threatening vascular disease.
 

Key Benefits of the Journal of Critical Limb Ischemia

• The only peer-reviewed journal dedicated solely to CLTI and severe PAD
• Indexed in SCOPUS and preserved in the CLOCKSS repository
• Reviewed by a multidisciplinary editorial board of clinical experts
• Quarterly issues featuring original research, trials, and clinical guidance
• Read by interventional cardiologists, vascular surgeons, radiologists, podiatrists, and wound care specialists
• Promotes evidence-based, collaborative care to reduce amputations and improve outcomes

Access the journal: clijournal.com
 

Who Is Dr. Jos C. van den Berg?

Dr. Jos C. van den Berg is an internationally respected interventional radiologist and academic leader with over 30 years of clinical and research experience. He currently serves as Associate Professor of Radiology at the University of Bern in Switzerland and Head of Interventional Radiology at Clinica Luganese Moncucco in Lugano.

• Medical degree from State University of Leiden, The Netherlands
• Former Head of Radiology, St. Antonius Hospital, Nieuwegein
• Author of 270+ peer-reviewed publications
• Editorial board member for leading vascular and radiology journals
• Contributor to ESVS and IWGDF clinical guidelines
• Chair of the European chapter of CLIGS
• Course director and faculty at AMP Europe and the European Vascular Course
   

Why This Appointment Matters

Appointing Dr. van den Berg strengthens the scientific leadership and editorial excellence of the Journal of Critical Limb Ischemia.

• Cause: Strategic editorial leadership transition by HMP Global and CLIGS
• Effect: Enhanced editorial rigor, expanded global reach, and increased scientific visibility
• Impact: Supports JCLI’s mission to advance multidisciplinary CLTI care and reduce preventable amputations
   

Statements from Key Leaders

“I am excited to take on the role of Editor-in-Chief of the Journal of Critical Limb Ischemia. The journal fills a critical gap in the scientific literature by focusing exclusively on CLTI and PAD. I am committed to maintaining its scientific rigor and expanding its global readership.”
— Dr. Jos C. van den Berg, MD, PhD, Associate Professor of Radiology, University of Bern

“CLIGS is honored to appoint Prof. van den Berg to this pivotal role. His depth of experience will guide the journal’s future and help fulfill its mission to improve outcomes for CLTI patients worldwide.”
— Dr. Barry Katzen, MD, President and Founding Board Member, Critical Limb Ischemia Global Society
 

About the Critical Limb Ischemia Global Society (CLIGS)

Founded in 2016, the Critical Limb Ischemia Global Society is a nonprofit, multidisciplinary organization dedicated to reducing the global burden of chronic limb-threatening ischemia. CLIGS leads initiatives in:

• Clinical education and guideline development
• Amputation prevention and patient advocacy
• Multidisciplinary collaboration across vascular care specialties

Learn more: cliglobalsociety.org
 

About HMP Global

HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit hmpglobal.com.